MX9102325A - Formas de dosis farmaceuticas de almacalante y procedimiento para su obtencion. - Google Patents

Formas de dosis farmaceuticas de almacalante y procedimiento para su obtencion.

Info

Publication number
MX9102325A
MX9102325A MX9102325A MX9102325A MX9102325A MX 9102325 A MX9102325 A MX 9102325A MX 9102325 A MX9102325 A MX 9102325A MX 9102325 A MX9102325 A MX 9102325A MX 9102325 A MX9102325 A MX 9102325A
Authority
MX
Mexico
Prior art keywords
almacalante
procedure
obtaining
dosage forms
pharmaceutical dosage
Prior art date
Application number
MX9102325A
Other languages
English (en)
Spanish (es)
Inventor
Kjell Hjalmar Andersson
Per Johan
Gunnar Lundberg
Leif Roger
Simonsson Karin Hele Johansson
Wingstrand
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of MX9102325A publication Critical patent/MX9102325A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/795Polymers containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Treatment Of Metals (AREA)
MX9102325A 1990-12-07 1991-12-02 Formas de dosis farmaceuticas de almacalante y procedimiento para su obtencion. MX9102325A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003902A SE9003902D0 (sv) 1990-12-07 1990-12-07 Solid dosage forms of a drug

Publications (1)

Publication Number Publication Date
MX9102325A true MX9102325A (es) 1992-06-01

Family

ID=20381121

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9102325A MX9102325A (es) 1990-12-07 1991-12-02 Formas de dosis farmaceuticas de almacalante y procedimiento para su obtencion.

Country Status (26)

Country Link
EP (1) EP0560821A1 (sh)
JP (1) JPH06503312A (sh)
CN (1) CN1063039A (sh)
AP (1) AP258A (sh)
AU (1) AU8930791A (sh)
BG (1) BG97851A (sh)
CA (1) CA2097178A1 (sh)
CZ (1) CZ103793A3 (sh)
FI (1) FI932554A (sh)
HU (1) HUT64217A (sh)
IE (1) IE914137A1 (sh)
IL (1) IL100150A0 (sh)
IS (1) IS3788A7 (sh)
LT (1) LTIP1717A (sh)
MA (1) MA22355A1 (sh)
MX (1) MX9102325A (sh)
MY (1) MY106776A (sh)
NZ (1) NZ240731A (sh)
PT (1) PT99719A (sh)
SE (1) SE9003902D0 (sh)
SK (1) SK55693A3 (sh)
TN (1) TNSN91117A1 (sh)
TW (1) TW215057B (sh)
WO (1) WO1992010172A1 (sh)
YU (1) YU186891A (sh)
ZA (1) ZA919264B (sh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19602757A1 (de) 1996-01-26 1997-07-31 Boehringer Mannheim Gmbh Feste Instant-Release-Darreichungsformen und Verfahren zu ihrer Herstellung
GB9611328D0 (en) * 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
JP4504467B2 (ja) * 1998-07-30 2010-07-14 佐藤製薬株式会社 口腔内崩壊性錠剤
JP7426685B2 (ja) * 2018-06-14 2024-02-02 株式会社東洋新薬 錠剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8705150D0 (sv) * 1987-12-23 1987-12-23 Haessle Ab Novel antiarrhythmic agents
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
SE8902236D0 (sv) * 1989-06-20 1989-06-20 Haessle Ab Novel polystyrenesulfonate

Also Published As

Publication number Publication date
SE9003902D0 (sv) 1990-12-07
YU186891A (sh) 1994-04-05
NZ240731A (en) 1993-10-26
CZ103793A3 (en) 1994-02-16
SK55693A3 (en) 1993-10-06
AP258A (en) 1993-06-03
EP0560821A1 (en) 1993-09-22
PT99719A (pt) 1992-10-30
CN1063039A (zh) 1992-07-29
IL100150A0 (en) 1992-08-18
HU9301670D0 (en) 1993-09-28
AU8930791A (en) 1992-07-08
MA22355A1 (fr) 1992-07-01
IS3788A7 (is) 1992-06-08
TNSN91117A1 (fr) 1992-10-25
JPH06503312A (ja) 1994-04-14
WO1992010172A1 (en) 1992-06-25
TW215057B (sh) 1993-10-21
BG97851A (en) 1994-04-29
ZA919264B (en) 1992-08-26
LTIP1717A (en) 1995-07-25
CA2097178A1 (en) 1992-06-08
MY106776A (en) 1995-07-31
FI932554A (fi) 1993-06-08
HUT64217A (en) 1993-12-28
AP9100338A0 (en) 1992-01-31
FI932554A0 (fi) 1993-06-04
IE914137A1 (en) 1992-06-17

Similar Documents

Publication Publication Date Title
MX23672A (es) Derivados de glicopeptidos y procedimiento para su preparacion.
MX17752A (es) Formulaciones farmaceuticas y procedimiento para prepararlas
ES551441A0 (es) Procedimiento para el tratamiento de formas de dosificacion farmaceuticas
MX9205392A (es) Triazolcarbozamidas herbicidas y procedimiento para su obtencion.
IT1183060B (it) Procedimento di preparazione. cefem composti ad azione farmaceutica e relativo
MX9202022A (es) Derivados de pirazina y proceso para su preparacion.
MX9201847A (es) Derivados heterociclicos de antiserotoninas, procedimiento para su preparacion y medicamentos que los contienen.
IT1143009B (it) Composti farmaceutici ad azione antisecretiva e procedimento di preparazione
MX9100856A (es) Rotogranulaciones y revestimientos enmascarantes de sabor para la preparacion de tabletas farmaceuticas masticables
DE3582594D1 (de) Proglumid und dessen pharmazeutische zusammensetzungen zur anwendung bei der behandlung von neoplastischen affektionen.
MX9203836A (es) Derivados de acido-4-amino-3-hidroxicarboxilico y proceso para su preparacion.
MX9100357A (es) Composiciones farmaceuticas estabilizadas y procedimiento para su preparacion
MX9102325A (es) Formas de dosis farmaceuticas de almacalante y procedimiento para su obtencion.
MX9100742A (es) Composicion farmaceutica y procedimiento para su preparacion
MX9102499A (es) Derivados de benzamida, procedimiento para su preparacion y composicion farmaceutica que los contiene.
MX9101081A (es) Compuestos fungicidamente activos y procedimiento para su preparacion
MX9102792A (es) D-aminoacido-axidasa inmovilizada y su empleo para la preparacion de medicamentos.
MX9207619A (es) Derivados de bencenmetanamina heterocilcicamente substituida y procedimiento para su preparacion.
IT8321684A0 (it) Derivati di piridazinoni impiegabili come sostanze medicinali e procedimenti per laloro fabbricazione.
MX9102324A (es) Pirimidilamidoximas substituidas y procedimiento para su obtencion.
MX9102683A (es) Derivados de cefalosporina, procedimiento para su preparacion y composicion farmaceutica que los contiene.
IT8023389A0 (it) Procedimento e batteria di elementi costruttivi per la costruzione di ambienti igienico-sanitari.
NO911298D0 (no) Farmasoeytisk preparat og anvendelse derav.
MX9201540A (es) Derivados de amidina y proceso para su preparacion.
AR231532A1 (es) Procedimiento para la preparacion de derivados de n,n-ditosil o dibencicloxi-carbonil-cistil bis-/2,4-dibromo-6-n-metil-n-ciclomexil-amino-metil anilida y una sal de adicion de los mismos